Document is current
Any future updates will be listed below
-
Authors
Agema, Bram C. https://orcid.org/0000-0003-1825-2911
Kocher, Tolra
Öztürk, Ayşenur B.
Giraud, Eline L.
van Erp, Nielka P.
de Winter, Brenda C. M.
Mathijssen, Ron H. J.
Koolen, Stijn L. W.
Koch, Birgit C. P.
Sassen, Sebastiaan D. T.
- License Information
-
More Information
Article History
Accepted: 6 September 2024
First Online: 27 September 2024
Declarations
:
: No funding was received for this work.
: The authors declared no competing interests for this work.
: The studies described in this paper have been accepted by an ethical board and written informed consent to use and publish anonymous data was obtained when deemed necessary by the ethical board.
: All imatinib patients gave consent to participate in the described prospective clinical trials (see manuscript). The medical ethical committee gave consent to use data from anonymized patients treated with vancomycin (see manuscript).
: Not applicable.
: Data are available upon reasonable request; the code has been provided as supplementary information.
: Available in the supplementary files.
: All authors wrote and reviewed the manuscript; B.C.A. and S.D.T.S. designed the research; B.C.A., T.K., A.B.Ö., and S.D.T.S. performed the research; B.C.A., T.K., A.B.Ö., B.C.M.d.W., S.L.W.K., and S.D.T.S. analyzed the data. This work has not been previously published.
